Royce & Associates
INSP icon

Royce & Associates’s Inspire Medical Systems INSP Stock Holding History

Royce & Associates’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$240K Buy
+3,467
New +$207K ﹤0.01% 733
2024
Q1 		– Sell
-42,269
Closed -$8.6M – 903
2023
Q4 		$8.6M Buy
42,269
+28,781
+213% +$4.66M 0.08% 357
2023
Q3 		$2.68M Sell
13,488
-3,000
-18% -$757K 0.03% 607
2023
Q2 		$5.35M Hold
16,488
– – 0.05% 479
2023
Q1 		$3.86M Buy
16,488
+4,000
+32% +$1.01M 0.04% 546
2022
Q4 		$3.15M Sell
12,488
-8,000
-39% -$1.71M 0.03% 573
2022
Q3 		$3.63M Sell
20,488
-10,000
-33% -$2.01M 0.04% 520
2022
Q2 		$5.57M Buy
30,488
+10,000
+49% +$1.99M 0.06% 441
2022
Q1 		$5.26M Buy
20,488
+16,000
+357% +$3.66M 0.04% 534
2021
Q4 		$1.03M Buy
+4,488
New +$1.1M 0.01% 803

Other funds holding INSP

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Royce & Associates's INSP Position: Q3 2026 in Review

Royce & Associates opened a new position in Inspire Medical Systems (INSP) in Q3 2026: 3,467 shares worth $240K. The stake represents ﹤0.01% of the portfolio and ranks #733 among its holdings. This is a return to the name: Royce & Associates previously reported a position in INSP as recently as Q4 2023.

Royce & Associates first reported a position in INSP in Q4 2021 and has held it in 10 quarters since. The position peaked at $8.6M in Q4 2023. 227 funds tracked by Wall St. Rank hold INSP as of Q3 2026.

  • Royce & Associates held 3,467 shares of Inspire Medical Systems worth $240K as of Q3 2026.
  • Inspire Medical Systems was a new Royce & Associates position in Q3 2026.
  • Inspire Medical Systems made up ﹤0.01% of Royce & Associates's portfolio in Q3 2026, its #733 holding.
  • Royce & Associates first reported a position in Inspire Medical Systems in Q4 2021 and has held it in 10 quarters since.
  • Royce & Associates's Inspire Medical Systems position peaked at $8.6M in Q4 2023.
  • 227 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2026.

Based on Royce & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.